Belgium· BE-AMP-SAM660606-00
Vyvgart 20 mg/ml
A efgartigimod alfa product containing efgartigimod alfa, registered in Belgium by Argenx. The same ATC class is registered in 4 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Efgartigimod alfa is registered in 4 of 19 countries.
Countries holding a registration under ATC L04AA58 (efgartigimod alfa), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 2 of them publish a price we can compare per daily dose
Efgartigimod alfa · ATC L04AA58
4 / 19 countries
- Belgiumprice
- Canada
- Ireland
- Polandprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Efgartigimod Alfa
- Manufacturer
- Argenx
- Country
- Belgium (BE)
- ATC code
- L04AA58
- ATC class
- Efgartigimod alfa
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 2
- be_apb7739303
- be_apb4744645
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Efgartigimod alfa in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwitzerlandVyvgart 400 mg/20ml, solution à diluer pour perfusionargenx Switzerland SA
- CzechiaVYVGARTargenx BV, Gent
- FinlandVyvgartArgenx
- IrelandVyvgart 20 mg/mL concentrate for solution for infusionArgenx
- IcelandVyvgartArgenx BV
- PolandVyvgartargenx BV
- SwedenVyvgart 20 mg/ml Koncentrat till infusionsvätska, lösningArgenx
- SpainVYVGART 1.000 MG SOLUCION INYECTABLEArgenx B.V.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Vyvgart
- Liechtenstein · Vyvgart
- Norway · Vyvgart
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ee173529-da0b-4654-a36d-95887fca6bb5 GET /v1/drugs/ee173529-da0b-4654-a36d-95887fca6bb5?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Concentrate for solution for infusion",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Vyvgart 20 mg/ml",
"name_fr": "Vyvgart 20 mg/ml",
"name_nl": "Vyvgart 20 mg/ml",
"amp_code": "SAM660606-00",
"strengths": [
"20.0000",
"20.0000",
"67.2000"
],
"pack_count": 1,
"substances": [
"Efgartigimod Alfa",
"Polysorbate 80",
"Sodium"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Efgartigimod Alfa",
"authorisation_numbers": [
"EU/1/22/1674/001"
]
}See everything about efgartigimod alfa.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.